Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series

Documenti analoghi

• Subretinal injection of tissue plasminogen activator for submacular hemorrhage – When and how to do
  di: R. Sriram, et al.
  Pubblicazione: (2025-09-01)
• Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration
  di: Remzi Avcı, et al.
  Pubblicazione: (2021-01-01)
• Pars plana vitrectomy with tissue plasminogen activator for traumatic submacular hemorrhage
  di: Wilson X. Wang, et al.
  Pubblicazione: (2025-09-01)
• Vitrectomy with subretinal tissue plasminogen activator and intravitreal injection of bevacizumab in the treatment of submacular haemorrhage secondary to wet AMD – case series
  di: Agnieszka Nowosielska, et al.
  Pubblicazione: (2024-03-01)
• The surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of AMD with automated subretinal injection
  di: A. D. Ovchinnikova, et al.
  Pubblicazione: (2021-01-01)